The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 322.00
Bid: 322.00
Ask: 323.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.311%)
Open: 322.00
High: 323.50
Low: 319.50
Prev. Close: 322.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

31 Mar 2020 07:00

RNS Number : 1265I
Morgan Advanced Materials PLC
31 March 2020
 

 

 

Press Release

Morgan Advanced Materials plc

31 March 2020

 

COVID-19 update

 

 

Our employees and customers

 

The health, safety and wellbeing of our employees is our absolute priority. We are following the varying advice of local governments around the world as the situation develops, and have wound down some operations and closed sites in geographies where that is required. We also continue operations with heightened safety measures where appropriate, and we continue to service customers in key industries such as healthcare, food production, energy and critical infrastructure.

 

Financial and operational performance

 

Sales for the 12 weeks to 21 March 2020 were 3.2% lower for the Group, on an organic constant-currency basis, compared to the same period of last year. Excluding China, the group was 0.2% lower than the prior year.

 

By business, the organic-constant currency trends for the same period compared to prior year are as follows. Within the Carbon & Technical Ceramics division, sales were 0.6% lower than the prior year, with growth in Seals & Bearings partially offsetting a decline in Electrical Carbon, and with Technical Ceramics broadly flat. Sales for the Thermal Products division were 6.7% lower than the prior year.

 

While we are currently seeing the position improve in China, with all of our factories there reopened, the COVID-19 outbreak has escalated globally. At this point we have six businesses closed across Italy, India and South Africa. The situation remains highly uncertain and it is therefore impossible to predict with any degree of certainty the impact this will have. We are consequently withdrawing our previous guidance for 2020.

 

Mitigating actions and financial position

 

While significant uncertainty exists around the impact of COVID-19, we have taken immediate action to reduce costs and improve cash flow and liquidity. These include reductions to capital expenditure other than for vital health, safety and environmental matters, a temporary hiring freeze for all but the most critical roles, and a curtailment of discretionary expenditure. The Board members have agreed to a 30% salary reduction, effective 1 April, for the rest of the financial year.

 

With respect to our financial position, we have no debt maturities until 2023, and as at 31 December 2019 we had:

 

· net debt excluding lease liabilities of £157 million

· a net debt / EBITDA ratio (pre-IFRS16) of 1.0 compared to a covenant not to exceed 3.0

· interest cover (pre-IFRS16) of 17.6 compared to a covenant to be greater than 4.0

· cash of £68 million and £150 million of headroom under our committed £200 million revolving credit facility.

 

Despite the strength of the Group's balance sheet, given the rising level of uncertainty as to how the situation will develop, we are taking all appropriate measures to preserve the Group's cash and liquidity position. Accordingly, the Board has decided to withdraw the proposed 2019 final dividend which was due to be approved at our forthcoming Annual General Meeting. The Board has also decided to suspend the dividend payable on the preference shares. We will review these dividend decisions later in the year once the outlook is clearer.

 

We have a global diversified business, a clear strategy and a strong balance sheet. We remain focussed on protecting our colleagues, containing our costs and preserving our financial position.

 

 

 

This announcement contains inside information. The person responsible for the release of this announcement on behalf of Morgan Advanced Materials plc is Peter Turner, Chief Financial Officer.

 

 

For further enquiries:

 

Pete Raby

Morgan Advanced Materials plc

01753 837 000

Peter Turner

 

Nina Coad

 

 

Brunswick

 

0207 404 5959 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFLFSDVDIIVII
Date   Source Headline
10th May 20197:00 amRNSTrading Update
7th May 20194:36 pmRNSDirectorate Change
8th Apr 20195:29 pmRNSDirector/PDMR Shareholding
3rd Apr 201911:22 amRNSAnnual Financial Report
19th Mar 20199:47 amRNSDirector/PDMR Shareholding
19th Mar 20199:44 amRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSFinal Results
17th Dec 201810:51 amRNSBlock listing Interim Review
21st Nov 20182:36 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSDivestment of Composites and Defence Systems
9th Nov 20187:00 amRNSTrading Update
22nd Oct 20185:17 pmRNSHolding(s) in Company
28th Sep 20188:17 amRNSCompletion of Bank Refinancing
6th Aug 20189:24 amRNSDirector/PDMR Shareholding
1st Aug 20188:54 amRNSDirector/PDMR Shareholding
26th Jul 20187:00 amRNSHalf-year results
2nd Jul 20182:37 pmRNS2017 Environmental, Health and Safety Report
2nd Jul 20187:00 amRNSDirectorate Change
15th Jun 20189:00 amRNSBlock listing Interim Review
11th May 20181:32 pmRNSResult of AGM
1st May 20182:08 pmRNSDirector/PDMR Shareholding
23rd Apr 20187:00 amRNSQ1 Trading Update
10th Apr 20183:31 pmRNSAnnual Financial Report
29th Mar 20183:47 pmRNSHolding(s) in Company
21st Mar 20184:26 pmRNSDirector/PDMR Shareholding
21st Mar 20184:12 pmRNSDirector/PDMR Shareholding
21st Mar 201810:04 amRNSHolding(s) in Company
2nd Mar 201811:22 amRNSHolding(s) in Company
1st Mar 201811:31 amRNSDirector/PDMR Shareholding
27th Feb 20187:00 amRNSFull-year results for period ended 31 Dec 2017
24th Jan 20187:00 amRNSUS tax reform
2nd Jan 201810:32 amRNSDirector/PDMR Shareholding
15th Dec 20178:00 amRNSBlock listing Interim Review
11th Dec 20177:00 amRNSAdditional US pension payment
8th Dec 20172:22 pmRNSChange of Senior Independent Director
27th Nov 201710:29 amRNSHolding(s) in Company
6th Nov 20177:00 amRNSTrading update
26th Sep 201710:39 amRNSDirector/PDMR Shareholding
22nd Sep 20175:03 pmRNSDirector/PDMR Shareholding
5th Sep 201711:13 amRNSDirector/PDMR Shareholding
4th Sep 201712:09 pmRNSDirector/PDMR Shareholding
30th Aug 201712:31 pmRNSHolding(s) in Company
28th Jul 20177:00 amRNSHALF YEAR RESULTS FOR 6 MONTHS ENDED 30 JUNE 2017
24th Jul 201711:53 amRNSHalf year results notification
6th Jul 20173:44 pmRNSHolding(s) in Company
15th Jun 20179:39 amRNSBlock listing Interim Review
5th May 20171:52 pmRNSResult of AGM
5th May 20177:00 amRNSTrading Statement
28th Apr 20179:36 amRNSAppointment of Non-Executive Director
12th Apr 201710:53 amRNS2016 Environmental, Health and Safety Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.